Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
5.83
+0.04 (0.69%)
At close: Aug 7, 2026, 4:00 PM EDT
5.75
-0.08 (-1.37%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Savara Employees
Savara had 70 employees as of December 31, 2025. The number of employees increased by 11 or 18.64% compared to the previous year.
Employees
70
Change (1Y)
11
Growth (1Y)
18.64%
Revenue / Employee
n/a
Profits / Employee
-$1,849,743
Market Cap
1.48B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 678 |
| MannKind | 592 |
| Xencor | 260 |
| Monte Rosa Therapeutics | 187 |
| Innoviva | 159 |
| Absci | 140 |
| MoonLake Immunotherapeutics | 130 |
| ORIC Pharmaceuticals | 104 |
SVRA News
- 8 days ago - Savara announces EPO granted a patent covering formulation of Molbreevi - TheFly
- 8 days ago - Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041 - Business Wire
- 24 days ago - Savara Slides: Corporate presentation - Filings
- 5 weeks ago - Palvella Therapeutics appoints Savara CEO Matt Pauls to board - TheFly
- 2 months ago - Savara Announces New Employment Inducement Grant - Business Wire
- 2 months ago - Savara says CFO Dave Lowrance stepping down for health reasons - TheFly
- 2 months ago - Savara Announces Chief Financial and Administrative Officer Transition - Business Wire
- 2 months ago - Savara Transcript: AGM 2026 - Transcripts